ForecastedNational Institutes of Health

Undiagnosed Diseases Network (UDN) Clinical Networks of Diagnostic Excellence

Opportunity number PAR-27-137 · Assistance listing 93.853

Estimated deadline
May 25, 2027
Expected posting
Sep 10, 2026
Award size
Not listed
Total program funding
Not listed
Expected awards
Not listed
Cost sharing
Not required
Funding type
Cooperative agreement
Category
Health

Check this solicitation free

Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.

About this opportunity

NINDS intends to support multiple clinical Networks of Diagnostic Excellence (NODEs) as part of the next phase of the Undiagnosed Diseases Network (UDN). Unlike prior phases, clinical NODEs are expected to function as geographically distributed regional clinical networks rather than single-site centers. Each clinical NODE would establish and lead a regional network built on existing partnerships with academic medical centers, hospitals, clinics, federally qualified health centers, and other community-based clinical partners to broaden access to specialized diagnostic expertise and extend the reach of the UDN.

Clinical NODEs are expected to provide a coordinated, multidisciplinary and participant-centered evaluation of individuals with highly challenging, difficult-to-diagnose conditions. In collaboration with the Network, clinical NODEs will recruit and enroll participants, conduct medical record reviews, make enrollment determinations, communicate review outcomes and recommendations to participants and referring providers, and coordinate the clinical evaluation with local partner sites and referring providers, as appropriate.

In addition, clinical NODEs will participate in network collaborations to develop and test innovative, new diagnostic tools and strategies for both genomic and non-genomic conditions, support systematic re-evaluation of unsolved UDN cases, and conduct research to optimize participant access and experience. Clinical NODEs are also expected to participate in network governance and infrastructure; provide training to support consistent implementation of UDN processes and standards; incorporate participant and community input into workflows and engagement strategies, such as through a Community Advisory Board or comparable mechanisms; and monitor site performance.

Applications are not being solicited at this time. This Forecast is being published to provide potential applicants time to plan, establish collaborations, formalize regional partnerships, and prepare responsive projects.

Who can apply

  • County governments
  • State governments
  • Other Native American tribal organizations
  • Nonprofits with 501(c)(3) status
  • Independent school districts
  • Other (see eligibility)
  • Federally recognized tribal governments
  • Special district governments
  • Nonprofits without 501(c)(3) status
  • Small businesses
  • Private universities
  • City or township governments
  • Public and Indian housing authorities
  • For-profit organizations
  • Public and state universities

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.

Agency contact

UDN Program Staff

Please contact via email.

UDNProgramStaff@ninds.nih.gov
Write this proposal with Grantee
  • Reads the full solicitation and lays out every required section
  • Drafts each section with you, in your words
  • Checks the draft against every requirement before you submit
Official notice on Grants.gov

How to write it

All guides

More from NIH

All NIH funding

Get new funding every Monday

New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.

Details from Grants.gov, last updated Sep 10, 2026. Deadlines and requirements can change: always confirm them in the official notice.